Trials / Completed
CompletedNCT00292812
Clinical Effects of a Nucleotides-Supplemented Infant Formula
The Clinical Effects of an Infant Formula Supplemented With Various Concentrations of Nucleotides
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Soroka University Medical Center · Academic / Other
- Sex
- All
- Age
- 1 Day – 30 Days
- Healthy volunteers
- Accepted
Summary
The study hypothesis is that different concentrations of nucleotides' supplementation of an infant formula might affect differently growth and/or other clinical parameters in neonates.
Detailed description
Three groups of 50 newborn infants each, will be fed for 30 days an infant formula supplemented with either 4.9 mg/100 kcal or 10.6 mg/100 kcal of nucleotides or with no supplementation. Newborns will be monitored prospectively for the following outcome parameters: * Growth percentiles. * Behaviour and infantile colic. * Bowel habits. * Side effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nutritional supplementation (nucleotides) |
Timeline
- Start date
- 2006-03-01
- Completion
- 2007-10-01
- First posted
- 2006-02-16
- Last updated
- 2007-10-23
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00292812. Inclusion in this directory is not an endorsement.